全文获取类型
收费全文 | 12562篇 |
免费 | 1052篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 334篇 |
妇产科学 | 299篇 |
基础医学 | 1944篇 |
口腔科学 | 337篇 |
临床医学 | 1450篇 |
内科学 | 2899篇 |
皮肤病学 | 188篇 |
神经病学 | 847篇 |
特种医学 | 659篇 |
外科学 | 1430篇 |
综合类 | 227篇 |
一般理论 | 6篇 |
预防医学 | 1359篇 |
眼科学 | 132篇 |
药学 | 865篇 |
中国医学 | 5篇 |
肿瘤学 | 589篇 |
出版年
2021年 | 150篇 |
2019年 | 147篇 |
2018年 | 177篇 |
2017年 | 112篇 |
2016年 | 166篇 |
2015年 | 170篇 |
2014年 | 275篇 |
2013年 | 396篇 |
2012年 | 475篇 |
2011年 | 536篇 |
2010年 | 333篇 |
2009年 | 269篇 |
2008年 | 523篇 |
2007年 | 495篇 |
2006年 | 501篇 |
2005年 | 456篇 |
2004年 | 384篇 |
2003年 | 375篇 |
2002年 | 358篇 |
2001年 | 350篇 |
2000年 | 341篇 |
1999年 | 326篇 |
1998年 | 204篇 |
1997年 | 193篇 |
1996年 | 218篇 |
1995年 | 161篇 |
1994年 | 147篇 |
1993年 | 149篇 |
1992年 | 308篇 |
1991年 | 283篇 |
1990年 | 283篇 |
1989年 | 290篇 |
1988年 | 276篇 |
1987年 | 237篇 |
1986年 | 270篇 |
1985年 | 231篇 |
1984年 | 241篇 |
1983年 | 202篇 |
1982年 | 150篇 |
1981年 | 138篇 |
1980年 | 132篇 |
1979年 | 181篇 |
1978年 | 146篇 |
1977年 | 140篇 |
1976年 | 125篇 |
1975年 | 114篇 |
1974年 | 118篇 |
1973年 | 107篇 |
1972年 | 111篇 |
1968年 | 104篇 |
排序方式: 共有10000条查询结果,搜索用时 484 毫秒
1.
2.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
3.
4.
MATTHEW B. COLLIER C. ANDERSON ENGH JR. JAMES P. MCAULEY STUART D. GINN GERARD A. ENGH 蔡迅梓 《骨科动态》2006,2(2):93-99
背景:从关节和胫骨假体聚乙烯衬垫后表面转移磨损碎屑,是全膝关节置换术后假体周围骨溶解的主要原因。全膝人工关节假体设计随时问而发生变化,例如对胫骨盘近端表面的粗糙度和聚乙烯衬垫的灭菌方法。我们假设胫骨盘表面抛光和采用空气中γ射线照射之外的其他方法对衬垫灭菌,可降低骨溶解的发生率。方法:从1987年至1998年,我们采用后十字韧带保留型的解剖型组配式全膝人工关节假体系列。对300名患者施行365例全膝关节置换术。术后5至10年,对这些患者的膝关节摄正、侧位X线片。由两位关节置换专家对X线片上的骨溶解状况进行单独评定(骨溶解的界定标准为假体周围存在边缘清晰的非线性松质骨丢失区)。结果:在粗糙表面的胫骨盘的242例膝关节中,使用空气中γ射线照射灭菌的衬垫固定,有34%(82例)骨溶解阳性。用惰性气体中γ射线照射或没有照射的衬垫与抛光表面连接的98例膝关节中,有9%(9例)骨溶解阳性。骨溶解与六项因素相关,这些因素为:一项与患者(男性)相关、一项与胫骨盘(近端表面抛光)相关、三项与聚乙烯衬垫(加工的原材料、灭菌方法及存放时间)相关及一项与手术技术(股骨假体与胫骨假体间的过伸)相关。结论:在这类假体设计中,胫骨盘近端表面采用抛光及衬垫采用更为先进的灭菌方法(不用空气中γ射线照射灭菌)能显著减少骨溶解的发生率,但不能避免骨溶解。 相似文献
5.
6.
Dr. William A. Shaver MD Patrick Storms MD Dr. Walter L. Peterson MD 《Digestive diseases and sciences》1988,33(2):185-188
We have noted that colons of patients prepared for colonoscopy with Golytely, a nonabsorbable electrolyte lavage solution, frequently contain foam which may obscure small mucosal lesions. Therefore, a randomized, blinded controlled trial was performed to determine the prevalence of Golytely-induced foam and the effect of supplemental simethicone in decreasing the prevalence of foam. Foam was present in 32% of colons prepared with Golytely alone but in none of the colons prepared with Golytely supplemented with simethicone. In addition, only 5% of colons prepared with supplemental simethicone had residual stool noted at the time of colonoscopy, a significant improvement over the 39% prevalence of residual stool in colons prepared with Golytely alone. Addition of simethicone to Golytely lavage decreases the prevalence of colonic foam and residual stool. 相似文献
7.
Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas 总被引:1,自引:0,他引:1
H. von Holst E. Knochenhauer H. Blomgren V. P. Collins L. Ehn M. Lindquist G. Norén C. Peterson 《Acta neurochirurgica》1990,104(1-2):13-16
Summary Eight patients with malignant gliomas verified on CT scan, received an intravenous injection of 50 mg of Adriamycin R, 24 hours prior to surgical removal of the tumour. Peroperatively, both tumour and surrounding tissue specimens were obtained for determination of the tissue concentrations of Adriamycin and its reduced metabolite Adriamycinol. It was found that Adriamycin could be detected in tumour tissue from all patients. The concentration varied between 0,9 and 4,6 nmol/g tissue. In contrast, Adriamycin could only be detected in surrounding brain tissue from one patient.In anin vitro study a human malignant glioma cell line (U-251 MG) was exposed to various concentrations of Adriamycin for 24 hours. It was found that an intracellular drug concentration above 30 nmol/g cells caused a concentration dependent inhibition of cell growth. Thus, it is likely that the poor effect of Adriamycin on patients with malignant gliomas is due to an ineffective drug accumulation in the tumour tissue. 相似文献
8.
9.
By injecting small amounts of CO2 through a needle, one can move bowel or bladder from the intended path of instruments during interventional procedures. The technique worked well in six of seven cases in the pelvis and retroperitoneum; it was not effective in the mediastinum or midabdomen (n = 6). 相似文献
10.
K W Anquist S Panchanathan P C Rowe R G Peterson A Sirnick 《Canadian Medical Association journal》1991,145(8):965-968
OBJECTIVE: To determine whether the use of dimenhydrinate was associated with delay in the diagnosis and management of treatable illnesses or with direct adverse effects in children with vomiting presenting to an emergency department. DESIGN: Questionnaire survey and review of drug reaction and telephone inquiry records. SETTING: The emergency department of a tertiary care children's hospital and a provincial poison information centre. PATIENTS: The parents of 148 children who presented with vomiting completed the questionnaire. The database at the poison information centre included 474 reports of adverse drug reactions over an 8-year period and 105 reports of telephone inquiries over a 4-year period. MAIN RESULTS: Twenty-one (14%) of 148 children had received dimenhydrinate before arrival at the emergency department. The patients who had received dimenhydrinate were more likely than the others to present more than 12 hours after the onset of vomiting (14 [67%] of 21 v. 43 [34%] of 127, p less than 0.01). The discharge diagnoses for those who had received dimenhydrinate included asthma, pelvic inflammatory disease and urinary tract infection. No clinically important direct adverse reactions to dimenhydrinate were documented. CONCLUSIONS: The use of dimenhydrinate in children with vomiting is associated with a risk of delay in the diagnosis of treatable medical conditions. 相似文献